|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Operating activities | ||
| Net income | ||
| Adjustments to reconcile net income to net cash flows provided by operating activities: | ||
| Depreciation and amortization | ||
| Goodwill impairment | ||
| Gains on divestitures | ||
| Stock-based compensation | ||
| Charged to Costs and Expenses | ||
| Losses on foreign exchange transactions | ||
| Losses (gains) on investments, net | ||
| Deferred income taxes | ||
| Settlement losses | ||
| Other, net | ||
| Changes in assets and liabilities, excluding the effects of acquisitions and divestitures: | ||
| Accounts receivable | ||
| Contract and other assets | ||
| Accounts payable | ||
| Accrued expenses | ||
| Pension and postretirement benefit plans | ||
| Contract and other liabilities | ||
| Net cash flows provided by operating activities | ||
| Investing activities | ||
| Capital expenditures | ||
| Acquisitions, net of cash acquired | ||
| Proceeds from divestitures | ||
| Sales of investments | ||
| Purchases of investments | ||
| Other investing activities, net | ||
| Net cash flows used in investing activities | ||
| Financing activities | ||
| Proceeds from long-term debt | ||
| Repayments of long-term debt | ||
| Dividends to stockholders of UL Solutions | ||
| Dividends to non-controlling interest | ||
| Payment, Tax Withholding, Share-Based Payment Arrangement | ||
| Other financing activities, net | ||
| Net cash flows used in financing activities | ||
| Effect of exchange rate changes on cash and cash equivalents | ||
| Net decrease in cash and cash equivalents | ||
| Cash and cash equivalents | ||
| Beginning of period | ||
| End of period | ||
| Supplemental disclosures of cash flow information | ||
| Cash paid during the period for interest | ||
| Cash paid during the period for income taxes | ||
| Cash paid during the period for stock-based compensation | ||
| Noncash investing and financing activities | ||
| Capital expenditures funded by liabilities | ||
| Conversion of stock-based compensation awards to equity (Note 17) |
Loading...
